19:50 EST BioXcel Therapeutics (BTAI) trading halted, news pending
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTAI:
- BioXcel Therapeutics announces 1-for-16 reverse stock split
- BioXcel Therapeutics provides clinical, business update
- BioXcel Therapeutics price target lowered to $3 from $5 at H.C. Wainwright
- Biotech Alert: Searches spiking for these stocks today
- Bioxcel Therapeutics Appoints Dr. Rajiv Patni to Board
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue